Medium impact
Genotype-Guided Warfarin Dosing
Blue Cross & Blue Shield of Mississippi·Identified Jun 20, 2026
HCPCS G9413 is officially defined as "Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision." HCPCS G9413 is referenced in 1 tracked payer policy change from Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G9413 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.